Consensus on integrated application of domestic radiotherapy equipment——homogenized IMRT of nasopharyngeal carcinoma:equipment
Expert Group on Integrated Application of Domestic Radiotherapy Equipment;Chinese Society of Digital Medicine;Radiation Therapy Specialized Committee of Chongqing Medical Association;Radiation Therapy Specialized Committee of Chongqing Association of Integrative Medicine;Radiation Therapy Specialized Committee of Chongqing Anti-Cancer Association;West China Society of Therapeutic and Radiation Oncology
Abstract：Objective To solve the problem of severe homogenization and deficiency in intensity-modulated radiotherapy (IMRT) for nasopharyngeal carcinoma, and deliver expert consensus and recommendations from the perspectives of domestic accelerators and image-guided radiation therapy (IGRT) equipment. Methods By integrating the existing clinical data, the actual situation of domestic radiotherapy equipment and the recommendations of the consensus expert committee, the integrated application of domestic accelerators was discussed by enumerating the evidence-based medical grades. Results Taking IMRT for nasopharyngeal carcinoma as an example, expert consensus recommendations were delivered on the domestic accelerators and IGRT devices for radiotherapy, which provided reference for the diagnostic and therapeutic process for radiologists. Conclusion The formation of expert consensus promotes the homogenization of the treatment of nasopharyngeal carcinoma in primary hospitals and Grade Ⅲ Level A hospitals to certain extent.
. Consensus on integrated application of domestic radiotherapy equipment——homogenized IMRT of nasopharyngeal carcinoma:equipment[J]. Chinese Journal of Radiation Oncology, 2019, 28(8): 561-565.
[1] 梁锌,杨剑,高婷,等. 中国鼻咽癌流行概况[J]. 中国肿瘤,2016,25(11):835-840. DOI:10.11735/j.issn.1004-0242.2016.11. A001. Ling X,Yang J,Gao T,et al. Nasopharynx Cancer Epidemiology in China[J]. China Cancer,2016,25(11):835-840. DOI:10.11735/j.issn.1004-0242.2016.11. A001. [2] Zhang L,Huang Y,Hong S,et al. Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma:a multicentre,randomised,open-label,phase 3 trial[J]. Lancet,2016,388(10054):1883-1892. DOI:10.1016/S0140-6736(16)31388-5. [3] Huang PY,Mai HQ,Luo DH,et al. Induction-concurrent chemoradiotherapy versus induction chemotherapy and radiotherapy for locoregionally advanced nasopharyngeal carcinoma[J]. Ai Zheng,2009,28(10):1033-1042. [4] 苏胜发,赵充,韩非,等. 鼻咽癌适形调强放疗远期疗效分析[J]. 中华肿瘤防治杂志,2013,20(11):853-858. DOI:10.16073/j.cnki.cjcpt.2013.11.011. Su SF,Zhao C,Han F,et al. Long-term outcome of nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy[J]. Chin J Cancer Prev Treat,2013,20(11):853-858. DOI:10.16073/j.cnki.cjcpt.2013.11.011. [5] 郎锦义,王培,吴大可,等.2015年中国大陆放疗基本情况调查研究[J]. 中华放射肿瘤学杂志,2016,(6):541-545. DOI:10.3760/cma.j.issn.1001-4221.2016.06.001. Lang JY,Wang P,Wu DK,et al. An investigation of the basic situation of radiotherapy in mainland China in 2015[J]. Chin J Radiat Oncol,2016,(6):541-545. DOI:10.3760/cma.j.issn.1001-4221.2016.06.001. [6] 王宝亭,耿鸿武. 医疗器械蓝皮书中国医疗器械行业发展报告(2018)[M]. 北京:社会科学文献出版社,2018. Wang BT,Geng HW. Blue paper on medical devices china medical devices industry development report (2018)[M]. Beijing:Social science literature publishing house,2018. [7] Qu S,Liang ZG,Zhu XD. Advances and challenges in intensity-modulated radiotherapy for nasopharyngeal carcinoma[J]. As Pac J Cancer Prev,2015,16(5):1687-1692. DOI:10.7314/APJCP.2015.16.5.1687. [8] Zhu Y,Wang G,Li GH,et al. Digital medicine investigation on radiation therapy status of nasopharyngeal cancer in chongqing[J]. Digital Med,2018,4(4):184-190. DOI:10.4103/digm.digm_32_18. [9] 林木炎,杨绍洲,林意群,等.48台医用直线加速器应用质量检测结果分析[J]. 医疗设备信息,2002,22(4):22-36. DOI:10.3969/j.issn.1674-1633.2002.04.012. Lin MY,Yang SZ,Lin YQ,et al. Analysis of the application quality test results of 48 medical linear accelerators[J]. Med Equip Informat,2002,22(4):22-36. DOI:10.3969/j.issn.1674-1633.2002.04.012. [10] 陆有荣,刘立明,安晶刚,等. 广西医用直线加速器配置与性能检测结果分析[J]. 中国医学装备,2007,4(9):5-8. DOI:10.3969/j.issn.1672-8270.2007.09.002. [11] 冯泽臣,娄云,万玲,等. 北京市医用电子直线加速器性能检测结果分析[J]. 首都公共卫生,2013,7(6):244-247. DOI:10.16760/j.cnki.sdggws.2013.06.004. [12] 国家癌症中心/国家肿瘤诊疗质控中心. 放疗质量控制基本指南[M]. 北京:中华人民共和国国国家卫生健康委员会,2017. [13] 中华人民共和国国家质量监督检验检疫总局/中国国家标准化管理委员会. 医用电子加速器验收试验和周期检验规程[M]. 北京:中国标准出版社,2014. [14] Klein EE,Hanley J,Bayouth J,et al. Task Group 142 report:quality assurance of medical accelerators[J]. Med Phys,2009,36(9):4197-4212. DOI:10.1118/1.3190392.
2019, Vol. 28 
